8-[4-(furan-3-ylmethyl)piperazin-1-yl]-3-pyridin-4-ylimidazo[1,2-a]pyrazine;tris(2,2,2-trifluoroacetic acid)
C26H23F9N6O7 — CID 155833707
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[4-(furan-3-ylmethyl)piperazin-1-yl]-3-pyridin-4-ylimidazo[1,2-a]pyrazine;tris(2,2,2-trifluoroacetic acid)
8-[4-(furan-3-ylmethyl)piperazin-1-yl]-3-pyridin-4-ylimidazo[1,2-a]pyrazine;tris(2,2,2-trifluoroacetic acid) (PubChem CID 155833707) has the molecular formula C26H23F9N6O7 and a molecular weight of 702.49 g/mol. Its IUPAC name is 8-[4-(furan-3-ylmethyl)piperazin-1-yl]-3-pyridin-4-ylimidazo[1,2-a]pyrazine;tris(2,2,2-trifluoroacetic acid).
Molecular Properties
| Compound Name | 8-[4-(furan-3-ylmethyl)piperazin-1-yl]-3-pyridin-4-ylimidazo[1,2-a]pyrazine;tris(2,2,2-trifluoroacetic acid) |
|---|---|
| PubChem CID | 155833707 |
| Molecular Formula | C26H23F9N6O7 |
| Molecular Weight | 702.49 g/mol |
| Exact Mass | 702.15 |
| IUPAC Name | 8-[4-(furan-3-ylmethyl)piperazin-1-yl]-3-pyridin-4-ylimidazo[1,2-a]pyrazine;tris(2,2,2-trifluoroacetic acid) |
| SMILES | O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.c1cc(-c2cnc3c(N4CCN(Cc5ccoc5)CC4)nccn23)ccn1 |
| InChI | InChI=1S/C20H20N6O.3C2HF3O2/c1-4-21-5-2-17(1)18-13-23-20-19(22-6-7-26(18)20)25-10-8-24(9-11-25)14-16-3-12-27-15-16;3*3-2(4,5)1(6)7/h1-7,12-13,15H,8-11,14H2;3*(H,6,7) |
| InChIKey | DKIHICFJOFAEEA-UHFFFAOYSA-N |
| XLogP | 4.61 |
| TPSA | 174.60 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 702.49 |
| LogP ≤ 5 | 4.61 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155833707 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.